These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 24008031)

  • 1. [Acute urticaria associated to omalizumab treatment in a child with asthma].
    Velarde-Domínguez T; Pantoja-Alcantar JM; Martínez-Sáenz NP
    Rev Alerg Mex; 2012; 59(4):209-13. PubMed ID: 24008031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omalizumab: anti-IgE monoclonal antibody E25, E25, humanised anti-IgE MAb, IGE 025, monoclonal antibody E25, Olizumab, Xolair, rhuMAb-E25.
    BioDrugs; 2002; 16(5):380-6. PubMed ID: 12408744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Churg-strauss syndrome in patients treated with omalizumab.
    Wechsler ME; Wong DA; Miller MK; Lawrence-Miyasaki L
    Chest; 2009 Aug; 136(2):507-518. PubMed ID: 19411292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promising option in the prevention of idiopathic anaphylaxis: omalizumab.
    Demirtürk M; Gelincik A; Colakoğlu B; Dal M; Büyüköztürk S
    J Dermatol; 2012 Jun; 39(6):552-4. PubMed ID: 22390871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase.
    Maurer M; Altrichter S; Bieber T; Biedermann T; Bräutigam M; Seyfried S; Brehler R; Grabbe J; Hunzelmann N; Jakob T; Jung A; Kleine-Tebbe J; Mempel M; Meurer M; Reich K; Ruëff F; Schäkel K; Sengupta K; Sieder C; Simon JC; Wedi B; Zuberbier T; Mahler V; Staubach P
    J Allergy Clin Immunol; 2011 Jul; 128(1):202-209.e5. PubMed ID: 21636116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful management of Churg-Strauss syndrome using omalizumab as adjuvant immunomodulatory therapy: first documented pediatric case.
    Iglesias E; Camacho Lovillo M; Delgado Pecellín I; Lirola Cruz MJ; Falcón Neyra MD; Salazar Quero JC; Bernabeu-Wittel J; González Valencia JP; Neth O
    Pediatr Pulmonol; 2014 Mar; 49(3):E78-81. PubMed ID: 24136903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spotlight on omalizumab in allergic asthma.
    Bang LM; Plosker GL
    BioDrugs; 2004; 18(6):415-8. PubMed ID: 15571425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgE-Related Chronic Diseases and Anti-IgE-Based Treatments.
    Navinés-Ferrer A; Serrano-Candelas E; Molina-Molina GJ; Martín M
    J Immunol Res; 2016; 2016():8163803. PubMed ID: 28097159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omalizumab in the treatment of chronic urticaria.
    Francés L; Leiva-Salinas M; Silvestre JF
    Actas Dermosifiliogr; 2014; 105(1):45-52. PubMed ID: 23938072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of long-term safety of the anti-IgE antibody, omalizumab, in children with allergic asthma.
    Berger W; Gupta N; McAlary M; Fowler-Taylor A
    Ann Allergy Asthma Immunol; 2003 Aug; 91(2):182-8. PubMed ID: 12952113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy.
    Kaplan A; Ledford D; Ashby M; Canvin J; Zazzali JL; Conner E; Veith J; Kamath N; Staubach P; Jakob T; Stirling RG; Kuna P; Berger W; Maurer M; Rosén K
    J Allergy Clin Immunol; 2013 Jul; 132(1):101-9. PubMed ID: 23810097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dermatologic uses of omalizumabtitle.
    Chia JC; Mydlarski PR
    J Dermatolog Treat; 2017 Jun; 28(4):332-337. PubMed ID: 27759482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Partial response of solar urticaria to omalizumab therapy].
    Kowalzick L; Thiel W; C Bielfeld ; Ziegler H; Eickenscheidt L
    Hautarzt; 2017 Jun; 68(6):492-496. PubMed ID: 27995273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential role of omalizumab in the treatment of chronic urticaria.
    Stitt JM; Dreskin SC
    Immunotherapy; 2014; 6(6):691-7. PubMed ID: 25186602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Churg-Strauss vasculitis in a patient treated with omalizumab.
    Bargagli E; Madioni C; Olivieri C; Penza F; Rottoli P
    J Asthma; 2008 Mar; 45(2):115-6. PubMed ID: 18350402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of omalizumab in patients with food allergy.
    Rafi A; Do LT; Katz R; Sheinkopf LE; Simons CW; Klaustermeyer W
    Allergy Asthma Proc; 2010; 31(1):76-83. PubMed ID: 20167148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omalizumab: a review of its use in the treatment of allergic asthma.
    Plosker GL; Keam SJ
    BioDrugs; 2008; 22(3):189-204. PubMed ID: 18481901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of eosinophilic granulomatosis with poliangiitis (Churg-Strauss syndrome) and brain tumor in a patient after more than 7 years of omalizumab use: A case report.
    Borekci S; Aydin O; Hatemi G; Gemicioglu B
    Int J Immunopathol Pharmacol; 2015 Mar; 28(1):134-7. PubMed ID: 25816417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omalizumab in chronic urticaria: a retrospective series of 15 cases.
    Armengot-Carbo M; Velasco-Pastor M; Rodrigo-Nicolas B; Pont-Sanjuan V; Quecedo-Estebanez E; Gimeno-Carpio E
    Dermatol Ther; 2013; 26(3):257-9. PubMed ID: 23742285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chronic autoimmune urticaria: treatment with omalizumab].
    Máspero JF; Parisi CA; De Gennaro M; Benhabib O; Lampert M
    Arch Argent Pediatr; 2009 Oct; 107(5):452-6. PubMed ID: 19809768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.